Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan E Scott

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
SLAS Technology|March 16, 2026
Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contaminationIrene Georgiou, Sandra O'Neill, Colin Robinson, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2013
Using a fragment-based approach to target protein-protein interactionsDuncan E Scott, Matthias T Ehebauer, Tara Pukala, et al.
Chembiochem : a European Journal of Chemical Biology|September 30, 2008
Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediateAlessio Ciulli, Duncan E Scott, Michiyo Ando, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACsDuncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
Journal of Molecular Biology|October 12, 2016
Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51Tommaso Moschetti, Timothy Sharpe, Gerhard Fischer, et al.
Journal of Medicinal Chemistry|December 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool MoleculesTimothy P C Rooney, Gregory G Aldred, Helen K Boffey, et al.
Journal of Medicinal Chemistry|February 11, 2022
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding ModeHelen K Boffey, Timothy P C Rooney, Henriette M G Willems, et al.
Journal of Medicinal Chemistry|August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic AgentsSimon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
RSC Medicinal Chemistry|January 8, 2026
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferaseIrene Georgiou, Colin Robinson, Sean N O'Byrne, et al.
Cell Chemical Biology|March 4, 2021
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell deathDuncan E Scott, Nicola J Francis-Newton, May E Marsh, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
SLAS Technology|March 16, 2026
Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contaminationIrene Georgiou, Sandra O'Neill, Colin Robinson, et al.
Chembiochem : a European Journal of Chemical Biology|January 25, 2013
Using a fragment-based approach to target protein-protein interactionsDuncan E Scott, Matthias T Ehebauer, Tara Pukala, et al.
Chembiochem : a European Journal of Chemical Biology|September 30, 2008
Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediateAlessio Ciulli, Duncan E Scott, Michiyo Ando, et al.
ACS Medicinal Chemistry Letters|August 25, 2020
Systematic Investigation of the Permeability of Androgen Receptor PROTACsDuncan E Scott, Timothy P C Rooney, Elliott D Bayle, et al.
Journal of Molecular Biology|October 12, 2016
Engineering Archeal Surrogate Systems for the Development of Protein-Protein Interaction Inhibitors against Human RAD51Tommaso Moschetti, Timothy Sharpe, Gerhard Fischer, et al.
Journal of Medicinal Chemistry|December 14, 2022
The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool MoleculesTimothy P C Rooney, Gregory G Aldred, Helen K Boffey, et al.
Journal of Medicinal Chemistry|February 11, 2022
Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding ModeHelen K Boffey, Timothy P C Rooney, Henriette M G Willems, et al.
Journal of Medicinal Chemistry|August 27, 2024
Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic AgentsSimon R Stockwell, Duncan E Scott, Gerhard Fischer, et al.
RSC Medicinal Chemistry|January 8, 2026
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferaseIrene Georgiou, Colin Robinson, Sean N O'Byrne, et al.
Cell Chemical Biology|March 4, 2021
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell deathDuncan E Scott, Nicola J Francis-Newton, May E Marsh, et al.
Pageof 2